Our results are consistent with the notion that early in obesity reversal, rapid normalization of dysglycemia is matched by a robust improvement in hepatic steatosis and metabolism (though not insulin signaling responsiveness) (Jung et al. 2013, Cho et al. 2016). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.